Advancing Innovation in Rare Cancers
At TargetCancer Foundation, we believe everyone diagnosed with a rare cancer should have effective treatments and a chance to live.
Breaking Down Barriers in Rare Cancer Research Since 2009
TargetCancer Foundation works to advance the development of more effective and personalized treatments for people with rare cancers.
We do this by
Driving
innovative research
Connecting
the rare cancer community
Empowering
people with rare cancers
TargetCancer Foundation’s impact goes beyond the numbers.
Launched
1st
fully-remote precision medicine clinical trial for rare cancer
Enrolling
400
people with rare cancers in TCF-001 TRACK trial
Convened
Thousands
of rare cancer experts through TCF’s scientific meetings
Dedicated
15+ years
and millions of dollars to drive advances in rare and under-resourced cancers
Co-creating New Rare Cancer Tools and Pathways for Discovery
We convene and collaborate with key stakeholders, both organizations and individuals, to advance our shared goal of more effective and personalized treatments for everyone living with rare cancers.
People with rare cancers
and their loved ones
Researchers
studying rare cancers
Companies
developing new drugs and treatments
Advocacy organizations
offering condition-specific support
Medical professionals
caring for rare cancer patients
Government
regulators and policymakers
Precision Medicine Clinical Trial for Rare Cancers
TCF-001 TRACK is an innovative clinical trial enrolling 400 patients with rare cancers or cancer of unknown primary. Through a remote consenting process, patients can fully enroll in the TRACK study from their homes, without traveling to a clinical trial site.
Latest News
Why Isn’t Mental Health Care Routinely Part of Oncology Care?
This perspective is written by Nancy M. Gregory, MBA, CFE, CCEP, a cancer survivor, TCF volunteer, and...
Against All Odds
This post is written by Allen Chankowsky, TCF Community Member, Patient Advocate, and Author Against...
Upcoming Events
The team at TargetCancer has walked this path. They know, intimately, what families and researchers are going through, and they act as binders, bringing together the heavy hitters in science with families to operationalize medical progress.
Abby L.
Volunteer and TCF Community Member
